Japanese Classification of Esophageal Cancer, 11th Edition: part I.

Japanese Classification of Esophageal Cancer, 11th Edition: part I.
复制标题

日本食管癌的分类,第11版:第一部分。

DOI:
10.1007/s10388-016-0551-7
复制
发表时间:
2017
期刊:
Esophagus : official journal of the Japan Esophageal Society
影响因子:
--
通讯作者:
Japan Esophageal Society
Japan Esophageal Society
中科院分区:
其他
文献类型:
--
作者:
Japan Esophageal Society

文献摘要

被引文献

相似文献

1. 目的、对象和方法的描述 ................................................................................................................1.1十。目的 ......................................................................................................................................................................1.2十。对象 ........................................................................................................................................................................1.3十。描述的方法 ...........................................................................................................................................1.3十。1. 描述和缩写的原则 .................................................................................................10 2。临床方面 ................................................................................................................................................................12个2.1。原发肿瘤的描述 ..................................................................................................................................12个2.1。1. 原发性肿瘤,大小和圆周位置 ....................................................................12个2.1。2. 肿瘤的位置 ...............................................................................................................................................12个2.1。3. 宏观肿瘤类型 ................................................................................................................................13 2.1。4. 肿瘤浸润深度(T )..........................................................................................................................14个2.2。转移病灶来自食管癌食管cancerMetastatic病变 ........................................15 2.2。1. 淋巴结转移 ..................................................................................................................................15 2.2。2. 远处器官转移(M ).........................................................................................................................18 2.3。阶段 ..........................................................................................................................................................................18 2.4。多个主要癌症 .........................................................................................................................................18 3。手术方面 ...............................................................................................................................................................19 3.1。切除标本的处理 ......................................................................................................................19 3.2。描述原发肿瘤的手术结果和宏观研究 ...................................................19 3.2。1. 肿瘤大小 ...................................................................................................................................................19 3.2。2. 肿瘤手术边缘的距离 ..............................................................................................20 3.2。3. 宏观肿瘤类型 .............................................................................................................................20 3.2。4. 手术优势 ...........................................................................................................................................20 3.2。5. RM:径向边缘 .....................................................................................................................................20 3.3。校内的转移和多种癌症的食道 ............................................................................20 3.3。1. 即时通讯:校内的转移 ...........................................................................................................................20 3.3。2. 多种癌症的食道 .............................................................................................................20 3.4。淋巴结 .........................................................................................................................................................20 3.4。1. 准备切除淋巴结的病理检查 .........................................................20 3.4。2. 淋巴结转移的评分(N )......................................................................................................20 3.4。3. 淋巴结解剖(D )........................................................................................................................20 3.5。远处器官转移(M )................................................................................................................................21 3.6。残余肿瘤(右 )................................................................................................................................................21 3.7。Curativity(坏蛋 ).....................................................................................................................................................21 4。病理结果……
1. Purpose, object, and methods of descriptions................................................................................................................ 10 1.1. Purpose...................................................................................................................................................................... 10 1.2. Object........................................................................................................................................................................ 10 1.3. Methods of descriptions........................................................................................................................................... 10 1.3. 1. Principles of descriptions and abbreviations................................................................................................. 10 2. Clinical aspects................................................................................................................................................................ 12 2.1. Description of primary tumor.................................................................................................................................. 12 2.1. 1. Number of primary tumors, size and circumferential location.................................................................... 12 2.1. 2. Tumor location............................................................................................................................................... 12 2.1. 3. Macroscopic tumor type................................................................................................................................ 13 2.1. 4. Depth of tumor invasion (T).......................................................................................................................... 14 2.2. Metastatic lesions from esophageal cancerMetastatic lesions from esophageal cancer........................................ 15 2.2. 1. Lymph node metastasis.................................................................................................................................. 15 2.2. 2. Distant organ metastasis (M)......................................................................................................................... 18 2.3. Stage.......................................................................................................................................................................... 18 2.4. Multiple primary cancers......................................................................................................................................... 18 3. Surgical aspects............................................................................................................................................................... 19 3.1. Handling of the resected specimen...................................................................................................................... 19 3.2. Description of surgical findings and macroscopic findings of primary tumor................................................... 19 3.2. 1. Tumor size................................................................................................................................................... 19 3.2. 2. Distance from surgical margin to the tumor.............................................................................................. 20 3.2. 3. Macroscopic tumor type............................................................................................................................. 20 3.2. 4. Surgical margin........................................................................................................................................... 20 3.2. 5. RM: Radial margin..................................................................................................................................... 20 3.3. Intramural metastasis and multiple cancers of the esophagus............................................................................ 20 3.3. 1. IM: Intramural metastasis........................................................................................................................... 20 3.3. 2. Multiple cancers of the esophagus............................................................................................................. 20 3.4. Lymph nodes......................................................................................................................................................... 20 3.4. 1. Preparation of resected lymph nodes for pathological examination......................................................... 20 3.4. 2. Grading of lymph node metastasis (N)...................................................................................................... 20 3.4. 3. Lymph node dissection (D)........................................................................................................................ 20 3.5. Distant organ metastasis (M)................................................................................................................................ 21 3.6. Residual tumor (R)................................................................................................................................................ 21 3.7. Curativity (Cur)..................................................................................................................................................... 21 4. Pathological findings …